Could Antibody Discovery Lead to Better Flu Vaccines?
Medically reviewed by Drugs.com.
By Carole Tanzer Miller HealthDay Reporter
FRIDAY, Dec. 29, 2023 -- Researchers appear to have discovered a new weapon in the war on a particularly difficult foe.
They have identified a previously unrecognized class of antibodies that seem to be capable of neutralizing multiple strains of the flu virus.
Their findings, recently reported in the journal PLOS Biology, could lead to development of a vaccine that protects more broadly against influenza.
Each year, new vaccines are offered based on experts' best guesses about which strains will dominate. Sometimes they guess right, other times, not so much.
"We need annual influenza virus vaccines to keep pace with continuing viral evolution," the authors said in a journal news release. "Our work suggests that the barriers to eliciting more broadly protective immunity may be surprisingly low."
An array of studies are paving the way for vaccines that protect against multiple strains.
Many are focused on antibodies that can protect against flu subtypes known as H1 and H3 at the same time. These come in multiple strains and cause widespread infection.
Led by Holly Simmons of the University of Pittsburgh's School of Medicine, researchers in this study zeroed in on one target.
They focused on a small change found in some H1 strains in the sequence of building blocks that makes up hemagglutinin, a protein that plays a key role in the early stage of infection.
Some antibodies that neutralize H3 can also neutralize H1, but not if its hemagglutinin has this change, dubbed the 133a insertion, researchers explained.
Using blood samples from patients, they identified a class of antibodies that can neutralize some H3 strains as well as some H1 strains with or without the 133a insertion.
A vaccine coaxes the immune system to make antibodies that can bind to hemagglutinin and stop it from invading a person's cells. Different antibodies bind to parts of hemagglutinin differently, and the virus also changes over time, resulting in new strains that can evade the old antibodies.
Researchers said this work expands the list of antibodies that could possibly contribute to development of a vaccine with broader protection. It also adds to growing evidence supporting changes in how flu vaccines are manufactured, they added.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-29 22:15
Read more
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
- Expanded Admission Screening Protocol for Candida Auris Beneficial
- Half of U.S. Teens Stare at Screens More Than 4 Hours Per Day
- Scientists Track Brain Function as Folks Watch Movies
- Supply Chain Issues Less Likely to Yield Drug Shortages in Canada Versus U.S.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions